3401 North Central Avenue — Chicago, Illinois

3401 North Central Avenue is a clinical research site located in Chicago, Illinois, United States 60634.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

3401 North Central Avenue has participated in 1 clinical trials.

Therapeutic areas: Primary Fibromyalgia.

Sponsors: Tonix Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 3401 North Central Avenue?

3401 North Central Avenue has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 3401 North Central Avenue conducted?

3401 North Central Avenue has 1 clinical trials on record. Their work covers Primary Fibromyalgia.

Is 3401 North Central Avenue accredited by Crixeo Health?

3401 North Central Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 3401 North Central Avenue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.